盈康生命(300143)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

300143 盈康生命

已收盘 12-09 15:00:00

{"stockData":{"symbol":"300143","market":"SZ","secType":"STK","nameCN":"盈康生命","latestPrice":10.12,"timestamp":1765263807000,"preClose":10.07,"halted":0,"volume":5763600,"delay":0,"changeRate":0.005,"floatShares":641000000,"shares":749000000,"eps":0.1598,"marketStatus":"已收盘","change":0.05,"latestTime":"12-09 15:00:00","open":10.07,"high":10.35,"low":10.05,"amount":58688100,"amplitude":0.0298,"askPrice":10.12,"askSize":314,"bidPrice":10.11,"bidSize":16,"shortable":0,"etf":0,"ttmEps":0.1598,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1765330200000},"marketStatusCode":5,"adr":0,"adjPreClose":10.07,"symbolType":"stock","openAndCloseTimeList":[[1765243800000,1765251000000],[1765256400000,1765263600000]],"highLimit":11.08,"lowLimit":9.06,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":749451604,"isCdr":false,"pbRate":2.99,"roa":"--","peRate":63.329161,"roe":"3.5%","epsLYR":0.18,"committee":-0.052017,"marketValue":7584000000,"turnoverRate":0.009,"status":0,"floatMarketCap":6491000000},"requestUrl":"/m/hq/s/300143","defaultTab":"news","newsList":[{"id":"2589737383","title":"盈康生命：完成收购长沙珂信51%股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2589737383","media":"证券之星","labels":["shareholding","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589737383?lang=zh_cn&edition=full","pubTime":"2025-12-08 11:36","pubTimestamp":1765164998,"startTime":"0","endTime":"0","summary":"证券之星消息，盈康生命12月08日在投资者关系平台上答复投资者关心的问题。马总公开讲盈康已成功转型为科技型的公司了，那为何目前盈康的估值还这么低？2025年，公司审议通过了旨在完善治理与回报机制的相关制度。外延发展方面，公司于2025年上半年完成对长沙珂信肿瘤医院51%股权的收购，旨在进一步夯实在医疗服务领域的肿瘤特色，增厚业绩并增强持续经营能力。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120800008849.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,merge","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","300143"],"gpt_icon":0},{"id":"2589850227","title":"盈康生命：2025年完成收购长沙珂信肿瘤医院51%股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2589850227","media":"证券之星","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589850227?lang=zh_cn&edition=full","pubTime":"2025-12-05 11:48","pubTimestamp":1764906491,"startTime":"0","endTime":"0","summary":"公司去年提出市值管理，请问2025年公司在市值管理方面，做出了哪些具体行动？2025年，公司审议通过了旨在完善治理与回报机制的相关制度。外延发展方面，公司于2025年上半年完成对长沙珂信肿瘤医院51%股权的收购，旨在进一步夯实在医疗服务领域的肿瘤特色，增厚业绩并增强持续经营能力。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120500014118.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","300143"],"gpt_icon":0},{"id":"2588078737","title":"【私募调研记录】瑞博投资调研盈康生命","url":"https://stock-news.laohu8.com/highlight/detail?id=2588078737","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588078737?lang=zh_cn&edition=full","pubTime":"2025-12-04 08:04","pubTimestamp":1764806687,"startTime":"0","endTime":"0","summary":"根据市场公开信息及12月3日披露的机构调研信息，知名私募瑞博投资近期对1家上市公司进行了调研，相关名单如下：1）盈康生命 调研纪要：长沙珂信肿瘤医院于2015年9月正式开业，是三级肿瘤专科医院，湖南湘江新区癌症防治中心，省市医保定点单位。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://fund.stockstar.com/RB2025120400003809.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","300143"],"gpt_icon":0},{"id":"2585192618","title":"盈康生命：截至2025年11月20日股东总数为20,395户","url":"https://stock-news.laohu8.com/highlight/detail?id=2585192618","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585192618?lang=zh_cn&edition=full","pubTime":"2025-11-21 15:04","pubTimestamp":1763708659,"startTime":"0","endTime":"0","summary":"证券之星消息，盈康生命(300143)11月21日在投资者关系平台上答复投资者关心的问题。投资者提问：请问11月20日的股东人数多少，谢谢盈康生命回复：尊敬的投资者，您好！截至2025年11月20日，公司股东总数为20,395户。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112100017211.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300143","BK0236"],"gpt_icon":0},{"id":"2584793901","title":"上市公司，再卖一家大型医院！","url":"https://stock-news.laohu8.com/highlight/detail?id=2584793901","media":"医疗器械经销商...","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584793901?lang=zh_cn&edition=full","pubTime":"2025-11-20 11:56","pubTimestamp":1763610960,"startTime":"0","endTime":"0","summary":"如本次交易顺利完成，公司将不再持有昆明医科股权，昆明医科将不再纳入公司合并财务报表范围。公开资料显示，昆明医科肿瘤医院是二级肿瘤专科医院，同时是全国连锁专科医院，核定编制床位130张。据企查查信息，上述四家医院为公司旗下的全部医疗资产，这意味着永和智控正在剥离医疗业务。此外有消息称，永和智控曾经还投资过一家厦门永和医科肿瘤医院有限公司，不过目前该医院已显示“注销”状态。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2025-11-20/doc-infxzkvh1036058.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0259","BK0236","002795","300143"],"gpt_icon":0},{"id":"2583513137","title":"股市必读：盈康生命(300143)股东户数2.09万户，较上期增加1.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2583513137","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583513137?lang=zh_cn&edition=full","pubTime":"2025-11-14 02:26","pubTimestamp":1763058375,"startTime":"0","endTime":"0","summary":"截至2025年11月13日收盘，盈康生命报收于11.15元，上涨0.27%，换手率1.79%，成交量11.46万手，成交额1.26亿元。股本股东变化股东户数变动近日盈康生命披露，截至2025年11月10日公司股东户数为2.09万户，较10月31日增加240.0户，增幅为1.16%。户均持股数量由上期的3.63万股减少至3.59万股，户均持股市值为38.8万元。投资者： 董秘你好，截止到2025年11月10日股东人数是多少？","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111400000894.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","300143"],"gpt_icon":0},{"id":"2583995538","title":"盈康生命：公司实际控制人为海尔集团公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2583995538","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583995538?lang=zh_cn&edition=full","pubTime":"2025-11-13 09:15","pubTimestamp":1762996509,"startTime":"0","endTime":"0","summary":"证券之星消息，盈康生命(300143)11月13日在投资者关系平台上答复投资者关心的问题。投资者提问：市场有传闻，公司实际控制人为中国平安，请问是否属实？盈康生命回复：尊敬的投资者，您好！公司的实际控制人为海尔集团公司，相关信息已在定期报告及相关公告中披露。敬请广大投资者谨慎甄别市场信息。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111300009065.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","01169","300143"],"gpt_icon":0},{"id":"2582394020","title":"股市必读：盈康生命（300143）11月11日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2582394020","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582394020?lang=zh_cn&edition=full","pubTime":"2025-11-12 04:01","pubTimestamp":1762891289,"startTime":"0","endTime":"0","summary":"截至2025年11月11日收盘，盈康生命报收于10.81元，上涨0.0%，换手率0.74%，成交量4.73万手，成交额5097.73万元。盈康生命已从医疗集团成功转型为科技型公司。当日关注点来自交易信息汇总：11月11日主力资金净流出270.96万元，显示主力短期减持动向。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111200002982.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","300143"],"gpt_icon":0},{"id":"2582586073","title":"盈康生命：推动医疗服务向全生命周期健康管理升级","url":"https://stock-news.laohu8.com/highlight/detail?id=2582586073","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582586073?lang=zh_cn&edition=full","pubTime":"2025-11-11 15:07","pubTimestamp":1762844837,"startTime":"0","endTime":"0","summary":"全球医疗资源整合的具体合作进展、健康管理服务的客户拓展路径。公司始终致力于以科技创新驱动医疗服务升级，推动业务从传统疾病诊疗向覆盖用户全生命周期的健康管理升级。公司的长期战略是深耕细分病种，创新预诊治康新模式，拓宽营养、心理、康复等非治疗服务业务，逐步降低对传统病床资源的依赖，推动医疗服务与医疗器械协同发展，逐步实现从院内向院外延伸，从疾病精准治疗平台向科技赋能下的健康管理平台转型升级。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111100018597.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300143","BK0236"],"gpt_icon":0},{"id":"2581065662","title":"盈康生命“AI+医疗”亮相进博会 政策红利赋能长期价值","url":"https://stock-news.laohu8.com/highlight/detail?id=2581065662","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581065662?lang=zh_cn&edition=full","pubTime":"2025-11-06 18:51","pubTimestamp":1762426298,"startTime":"0","endTime":"0","summary":"恰逢国家“人工智能 + 医疗卫生”相关政策重磅出台，政策红利与技术创新形成双重共振，凭借先发技术优势与全产业链生态布局，盈康生命正迎来新一轮发展机遇期。进博会创新成果展现 “AI医院”重塑患者体验在进博会现场，盈康生命对未来医疗形态的构想——“AI医院”成为行业关注的热点。随着《实施意见》的落地实施，AI医疗行业将迎来加速发展期。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/SS2025110600032082.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300143","159891","BK0236"],"gpt_icon":0},{"id":"2580218457","title":"盈康生命：通过托管模式推动业务发展","url":"https://stock-news.laohu8.com/highlight/detail?id=2580218457","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580218457?lang=zh_cn&edition=full","pubTime":"2025-11-03 20:48","pubTimestamp":1762174091,"startTime":"0","endTime":"0","summary":"公司始终围绕肿瘤预/诊/治/康全产业链发展战略，通过内生式增长与外延式扩张相结合的方式推动业务发展。托管模式能充分发挥公司在医疗管理、品牌输出及资源整合方面的专业优势，确保托管医院在规范治理和医疗服务能力上持续提升，为其未来的稳健发展奠定坚实基础。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110300033209.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","300143"],"gpt_icon":0},{"id":"2580236900","title":"股市必读：盈康生命（300143）10月31日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2580236900","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580236900?lang=zh_cn&edition=full","pubTime":"2025-11-03 04:48","pubTimestamp":1762116491,"startTime":"0","endTime":"0","summary":"截至2025年10月31日收盘，盈康生命报收于10.66元，上涨1.43%，换手率0.97%，成交量6.22万手，成交额6621.52万元。董秘最新回复投资者： 查看已发布的最近几期财报，发现公司应收账款/利润的比例极高。未来公司仍将持续加强应收账款管理，相关财务数据及会计处理将按照相关披露要求在年度报告中予以披露。当日关注点来自交易信息汇总：10月31日主力资金净流出1138.17万元，散户资金净流入1090.43万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110300000990.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","300143"],"gpt_icon":0},{"id":"2579908238","title":"盈康生命：10月29日接受机构调研，兴证全球基金管理有限公司、天治基金管理有限公司等多家机构参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2579908238","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579908238?lang=zh_cn&edition=full","pubTime":"2025-10-29 19:59","pubTimestamp":1761739158,"startTime":"0","endTime":"0","summary":"如有相关进展公司会根据相关规定及时履行信息披露义务。盈康生命2025年三季报显示，前三季度公司主营收入13.58亿元，同比上升10.59%；归母净利润8683.89万元，同比上升5.2%；扣非净利润8543.06万元，同比上升12.53%；其中2025年第三季度，公司单季度主营收入5.15亿元，同比上升27.27%；单季度归母净利润2501.17万元，同比下降9.85%；单季度扣非净利润2484.07万元，同比下降1.01%；负债率38.53%，投资收益460.87万元，财务费用482.23万元，毛利率26.78%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102900040867.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","300143"],"gpt_icon":0},{"id":"2578607147","title":"盈康生命：截至2025年10月20日股东总数为19,744户","url":"https://stock-news.laohu8.com/highlight/detail?id=2578607147","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578607147?lang=zh_cn&edition=full","pubTime":"2025-10-28 11:33","pubTimestamp":1761622393,"startTime":"0","endTime":"0","summary":"证券之星消息，盈康生命(300143)10月28日在投资者关系平台上答复投资者关心的问题。投资者提问：请问公司最新10月20日的股东人数是多少，谢谢盈康生命回复：尊敬的投资者，您好！截至2025年10月20日，公司股东总数为19,744户。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102800017884.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300143","BK0236"],"gpt_icon":0},{"id":"2578417826","title":"营收13.58亿元！盈康生命前三季度营收净利双增","url":"https://stock-news.laohu8.com/highlight/detail?id=2578417826","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578417826?lang=zh_cn&edition=full","pubTime":"2025-10-27 21:09","pubTimestamp":1761570587,"startTime":"0","endTime":"0","summary":"10月27日晚，盈康生命披露2025年三季度报告。在此背景下，盈康生命前三季度业绩实现持续上涨，发展韧性凸显。其中公司前三季度扣非归母净利润同比增长12.53%，主营业务稳定发展。值得一提的是，今年以来盈康生命经营现金流状况持续改善，季度环比快速增长。在当前民营医疗行业分化加剧的背景下，盈康生命凭借AI技术构建的优势与盈利韧性，在医疗健康产业赛道中占据有利位置，稳健增长态势有望持续强化。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/SS2025102700034416.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300143"],"gpt_icon":0},{"id":"2576607040","title":"股市必读：盈康生命（300143）10月17日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2576607040","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2576607040?lang=zh_cn&edition=full","pubTime":"2025-10-20 02:13","pubTimestamp":1760897589,"startTime":"0","endTime":"0","summary":"截至2025年10月17日收盘，盈康生命报收于10.58元，下跌3.2%，换手率1.29%，成交量8.3万手，成交额8897.34万元。董秘最新回复投资者： 2025年欧洲肿瘤内科学会年会定于10月17日至10月21日在德国柏林举行，作为全球肿瘤学领域的顶级盛会，此次会议预计将汇集多项重磅临床研究成果。公司始终密切关注包括欧洲肿瘤内科学会年会在内的全球肿瘤领域前沿进展，并积极学习借鉴国际先进研究成果，以持续提升自身肿瘤诊疗服务水平。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102000000840.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300143","BK0236"],"gpt_icon":0},{"id":"2575276967","title":"盈康生命：推进智慧医院全链路能力部署","url":"https://stock-news.laohu8.com/highlight/detail?id=2575276967","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2575276967?lang=zh_cn&edition=full","pubTime":"2025-10-15 11:36","pubTimestamp":1760499410,"startTime":"0","endTime":"0","summary":"证券之星消息，盈康生命10月15日在投资者关系平台上答复投资者关心的问题。这与公司战略高度契合，公司将凭借在医疗服务领域的创新实践，积极把握此次合作机遇，充分整合双方资源优势，共同推进智慧医院解决方案中“患者就医体验”的全链路能力部署，以及探索高端医疗商保支付、家庭医疗软硬件一体化解决方案。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025101500015714.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300143","BK0236"],"gpt_icon":0},{"id":"2575469448","title":"股市必读：盈康生命(300143)股东户数1.98万户，较上期减少3.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2575469448","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2575469448?lang=zh_cn&edition=full","pubTime":"2025-10-13 05:45","pubTimestamp":1760305520,"startTime":"0","endTime":"0","summary":"截至2025年10月10日收盘，盈康生命报收于11.31元，下跌0.44%，换手率1.17%，成交量7.48万手，成交额8509.76万元。交易信息汇总资金流向10月10日主力资金净流出47.77万元；游资资金净流出86.47万元；散户资金净流入134.24万元。股本股东变化股东户数变动近日盈康生命披露，截至2025年9月30日公司股东户数为1.98万户，较9月19日减少661.0户，减幅为3.22%。户均持股数量由上期的3.66万股增加至3.78万股，户均持股市值为43.14万元。董秘最新回复投资者： 尊敬的董秘，您好。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025101300002111.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300143","BK0236"],"gpt_icon":0},{"id":"2574526147","title":"盈康生命：强化治理与主业发展提升价值","url":"https://stock-news.laohu8.com/highlight/detail?id=2574526147","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2574526147?lang=zh_cn&edition=full","pubTime":"2025-10-10 15:07","pubTimestamp":1760080036,"startTime":"0","endTime":"0","summary":"请问，在此新监管形势下，公司有何实质性举措来迅速扭转这一局面，以真正有效的市值管理回应市场和投资者的关切？公司高度重视市场和投资者的关切，始终将规范公司治理、维护投资者利益置于核心位置，始终将提升公司内在价值作为市值管理的根本，并持续深化既有市值管理举措：一、强化规范运作与内部治理：公司持续完善内部控制体系，严格执行信息披露制度，确保公司治理的规范性与透明度。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025101000017843.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","300143"],"gpt_icon":0},{"id":"2571264388","title":"股市必读：盈康生命（300143）9月26日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2571264388","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2571264388?lang=zh_cn&edition=full","pubTime":"2025-09-29 02:19","pubTimestamp":1759083553,"startTime":"0","endTime":"0","summary":"截至2025年9月26日收盘，盈康生命报收于11.1元，下跌1.16%，换手率1.11%，成交量7.1万手，成交额7933.88万元。董秘最新回复投资者： 董秘好！公司高度重视信息披露的公平性与合规性，依据相关规定披露股东人数。公司在脑机接口、康复机器人等前沿领域的布局始终以临床价值和长期战略为导向，坚持务实推进。当日关注点来自交易信息汇总：9月26日主力资金净流出838.61万元，显示主力资金呈离场态势。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025092900000881.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","300143"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1765304220524,"stockEarnings":[{"period":"1week","weight":0.009},{"period":"1month","weight":-0.0489},{"period":"3month","weight":-0.2221},{"period":"6month","weight":0.0243},{"period":"1year","weight":0.006},{"period":"ytd","weight":0.1}],"compareEarnings":[{"period":"1week","weight":0.003},{"period":"1month","weight":-0.022},{"period":"3month","weight":0.0255},{"period":"6month","weight":0.149},{"period":"1year","weight":0.149},{"period":"ytd","weight":0.1664}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"盈康生命科技股份有限公司","boardCode":"AI0083","boardName":"卫生","stockholders":"20122人(较上一季度减少1.34%)","perCapita":"31873股","listingDate":"2010-12-09","address":"山东省青岛市城阳区春阳路37号","registeredCapital":"74945万元","survey":"　　盈康生命科技股份有限公司的主营业务是提供以肿瘤为特色的医疗服务以及关键场景、关键设备医疗器械的研发、创新和服务。公司的主要产品是医疗设备及耗材产品、系统开发集成、医疗服务。","listedPrice":36},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"盈康生命(300143)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供盈康生命(300143)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"盈康生命,300143,盈康生命股票,盈康生命股票老虎,盈康生命股票老虎国际,盈康生命行情,盈康生命股票行情,盈康生命股价,盈康生命股市,盈康生命股票价格,盈康生命股票交易,盈康生命股票购买,盈康生命股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"盈康生命(300143)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供盈康生命(300143)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}